Introduction {#sec1}
============

Sirtuins are a conserved family of proteins comprising NAD^+^-dependent deacetylases and ADP-ribosyltransferases, and thus their functions are intrinsically connected with cellular metabolism \[[@B1]\]. Accumulating evidence has indicated that sirtuins are important sensors of energy status and that they protect cells against metabolic stress \[[@B2]\]. The biological regulatory functions of sirtuins vary from metabolism to cell survival, and sirtuins are involved in a range of physiological and pathological activities, such as control of ageing \[[@B3],[@B4]\], longevity pathways \[[@B5]\], DNA repair \[[@B6]\], transcriptional silencing \[[@B3]\], apoptosis \[[@B7]\], and the control of metabolic enzymes \[[@B8]\]. Sirtuins regulate these processes and are in turn regulated by diet and environmental stress. The mammalian sirtuin family contains seven members (SIRT1--7), which function to regulate metabolism in a non-redundant manner in many tissues \[[@B9]\]. Because each member exhibits distinct targets, functions, and subcellular localizations such as the nucleus (SIRT1, SIRT2, SIRT3, SIRT6, SIRT7), cytoplasm (SIRT1, SIRT2), and mitochondria (SIRT3, SIRT4, SIRT5), sirtuins can coordinate cellular responses to calorie restriction throughout the organism \[[@B10],[@B11]\].

SIRT4 is a member of mitochondrial sirtuins, which, because of their dependence on NAD^+^ as a cofactor, are metabolic sensors of cellular energy status \[[@B12]\]. Although it was originally reported to be an ADP-ribosyltransferase that is located in the mitochondrial matrix, SIRT4 is capable of removing several acyl-groups from lysine residues. Previous studies have reported that SIRT4 affects important biological pathways, especially those involved in metabolic diseases such as diabetes, obesity, and cancer \[[@B13]\].

*SIRT4* is highly expressed in islet β cells and can interact with adenine nucleotide translocator 2/3 (ANT2/3) and insulin degrading enzyme (IDE) \[[@B17]\]. SIRT4, through its ADP-ribosylation action, down-regulates the enzymatic activity of glutamate dehydrogenase (GDH) an enzyme, which promotes the metabolism of glutamate and glutamine, generates ATP, and stimulates insulin secretion. Therefore, SIRT4 represses the ability of β cells to secrete insulin in response to these amino acids \[[@B18]\]. On the other hand, SIRT4 removes three acyl moieties from lysine residues, namely methylglutaryl (MG)-, hydroxymethylglutaryl (HMG)-, and 3-methylglutaconyl (MGc)-lysine. The metabolites leading to these post-translational modifications are intermediates in leucine oxidation, and SIRT4 plays a key role in controlling this pathway \[[@B19]\]. Leucine has been identified as a potent insulin secretagogue in pancreatic islets \[[@B20]\], and studies have shown that dysregulated leucine metabolism in *SIRT4* KO mice leads to elevated basal and stimulated insulin secretion, which progressively develops into glucose intolerance and insulin resistance \[[@B21]\]. These findings identify a robust enzymatic activity for SIRT4, and suggest it as a crucial player in maintaining insulin secretion and glucose homeostasis.

SIRT4 acts as a key factor of adipogenesis, regulating the proliferation and differentiation of preadipocytes \[[@B22],[@B23]\]. Recent studies have identified that SIRT4 acts as a critical regulator of lipid homeostasis \[[@B24]\], inhibits fatty acid oxidation, and promotes lipid anabolism, which indicates that SIRT4 can regulate the balance between fat oxidation and synthesis. SIRT4 also regulates lipid homeostasis by deacetylating malonyl-CoA decarboxylase (MCD). By inhibiting MCD via deacetylation and resulting in a buildup of malonyl-CoA, SIRT4 reduces carnitine palmitoyltransferase-1 (CPT1) and subsequently blocks fatty acid oxidation. SIRT4 not only inhibits fatty acid oxidation (in skeletal muscle), but also induces lipogenesis in white fatty tissue through regulation of MCD activity \[[@B25]\]. Moreover, *SIRT4* KO mice showed increased fatty acid oxidation in various tissues such as the liver and myotubes, and were protected from obesity caused by high-fat diet, while remaining insulin resistant. Therefore, we can infer that SIRT4 regulates insulin sensitivity via energy metabolism in numerous metabolic tissues \[[@B22]\]. However, the molecular mechanisms associated with bovine *SIRT4* expression during adipose development are still unclear.

Transcriptional regulation is a vital physiological process in all living organisms. It is orchestrated by transcription factors (TFs) and regulatory proteins working coordinately together \[[@B26]\]. Transcriptional regulation allows the cell or organism to respond to a variety of intracellular and extracellular signals and thus adapt accordingly. Promoter is a region of DNA fragment, which may bind RNA polymerase, TFs, and other proteins for the successful initiation of transcription directly upstream of the particular gene \[[@B27]\]. In general, the promoter is located near the transcription start site (TSS) of the gene, and upstream on the DNA toward the 5′ region of the sense strand, and TFs can be divided in two main categories, namely activators and repressors \[[@B28]\]. The regulation of sequence-specific TFs such as E2F TF-1 (E2F1), CCAAT/enhancer-binding protein β (CEBPβ), homeobox A5 (HOXA5), interferon regulatory factor 4 (IRF4), paired box (PAX) 4 (PAX4), and cAMP responsive element-binding protein 1 (CREB1) is coordinated in part by the action of adipocytes \[[@B29]\]. However, the relationship between differentiation and the transcriptional regulation of the *SIRT4* promoter activity still needs to be clarified.

In the present study, the mechanisms underlying the molecular regulation of the *SIRT4* promoter were analyzed. In addition, we determined the relative mRNA expression pattern of bovine *SIRT4* in tissues, and its subcellular localization in bovine adipocytes. Thus, the present study aimed to elucidate the transcriptional regulation of *SIRT4* in bovine adipocyte differentiation.

Materials and methods {#sec2}
=====================

Ethics statement {#sec2-1}
----------------

All the experimental procedures on cattle used in the present study have been approved by the Experimental Animal Manage Committee (EAMC) of Northwest A&F University (2011--31,101,684). All the operations and experimental procedures complied with the national Standards of Laboratory Animal-Guideline for ethical review of animal welfare (GB/T 35892--2018) and Guide for the Care and Use of Laboratory Animals: Eighth Edition.

Animal sources and genomic DNA isolation {#sec2-2}
----------------------------------------

Qinchuan cattle were raised with free access to food and killed in the National Beef Cattle Improvement Center (Yangling, China). Genomic DNA was extracted from cattle blood samples, using standard method \[[@B35]\], and stored at −20°C until subsequent analyses.

Real-time quantitative PCR analysis of gene expression patterns {#sec2-3}
---------------------------------------------------------------

Fifteen tissue types (testis, subcutaneous fat, liver, lung, brain, kidney, longissimus thoracis, heart, spleen, large intestine, small intestine, omasum, rumen, abomasum, and reticulum) were obtained from three adult Qinchuan cattle. Total RNA was extracted from the tissues using a Total RNA kit (Tiangen, Beijing, China), and cDNA was generated using a PrimeScript™ RT Reagent kit with gDNA Eraser (Perfect Real Time; TaKaRa, Dalian, China). Real-time quantitative PCR (qPCR) was performed using a SYBR Green PCR Master Mix kit (TaKaRa, Dalian, China), the 7500 real time PCR System and the sequence detecting software SDS V 1.4.0 (Applied Biosystems, U.S.A.). All the procedures were performed in accordance with the manufacturer's instructions. All the primers used for qPCR are listed in [Table 1](#T1){ref-type="table"}. *β-actin* was included as the endogenous control gene. The relative expression levels of the target mRNAs were analyzed using the 2^−ΔΔ*C*^~t~ method \[[@B36]\].

###### Primers utilized in the present study

  Reaction                Name             Primer sequence (5′--3′)                        Tm (°C)   Product length (bp)   Amplified region
  ----------------------- ---------------- ----------------------------------------------- --------- --------------------- ------------------
  **RT-PCR**              β-actin          F: CACCAACTGGGACGACAT                           60.0      202                   320--521
                                           R: ATACAGGGACAGCACAGC                                                           
                          SIRT4            F: GGTCCTCTGCTTGGATTGTG                         60.0      131                   533--663
                                           R: CCTCGGTGAGAAAGACATCG                                                         
                          E2F1             F: TGCTCTCGGAGGACGCTGAC                         60.0      98                    698--795
                                           R: GATCACCATGACCATCTGCTCTGC                                                     
                          CEBPβ            F: GCACAGCGACGAGTACAAGATCC                      60.0      158                   816--973
                                           R: GCGACAGTTGCTCCACCTTCTTC                                                      
                          HOXA5            F: TAGTTCCGTGAGCGAGCAATTCAG                     60.0      80                    140--219
                                           R: GATCCATGCCATTGTAGCCGTAGC                                                     
                          IRF4             F: GCTCCACATCTGCCTCTACTACCG                     60.0      156                   807--962
                                           R: TTCTTCCTCTGGCTGCTGTCCTC                                                      
                          PAX4             F: GCCGTTACTATCGCACAGGTGTC                      60.0      153                   542--694
                                           R: CTGCACAGAGCTGGCGTTGG                                                         
                          CREB1            F: CACCTGCCATCACCACTGTCAC                       60.0      98                    448--545
                                           R: AGCCAGTTGTATTGCTCCTCCTTG                                                     
                          FABP4            F: TGAGATTTCCTTCAAATTGGG                        60.0      101                   243--343
                                           R: CTTGTACCAGAGCACCTTCATC                                                       
                          CEBPα            F: ATCTGCGAACACGAGACG                           60.0      73                    331--403
                                           R: CCAGGAACTCGTCGTTGAA                                                          
                          PPARγ            F: GAGATCACAGAGTACGCCAAG                        60.0      216                   1146--1361
                                           R: GGGCTCCATAAAGTCACCAA                                                         
                          ACCα             F: CTCCAACCTCAACCACTACGG                        60.0      171                   3949--4119
                                           R: GGGGAATCACAGAAGCAGCC                                                         
                          LPL              F: ACGATTATTGCTCAGCATGG                         60.0      130                   2955--3084
                                           R: ACTTTGTACAGGCACAACCG                                                         
  **Promoter cloning**    SIRT4-PF/PR      F: *CGGGGTACC*TGGTCGCCTAAGCAGGTCAA              66.0      2121                  −2077/+44
                                           R: *CCGCTCGAG*CCCACACTCTCACCTCCAAT                                              
                          SIRT4-P1         *CGGGGTACC*TGGTCGCCTAAGCAGGTCAA                 65.0      2121                  −2077/+44
                          SIRT4-P2         *CGGGGTACC*GGCATGTGATTTTTGTTGTGGC               65.0      1829                  −1785/+44
                          SIRT4-P3         *CGGGGTACC*CTACAGGCAGATTCTTTACCA                63.5      1589                  −1545/+44
                          SIRT4-P4         *CGGGGTACC*CGTGCTATCATGTCCAACTC                 64.0      1284                  −1240/+44
                          SIRT4-P5         *CGGGGTACC*GATCCAACCAATCAACCCTA                 62.0      1005                  −961/+44
                          SIRT4-P6         *CGGGGTACC*AACACGAGTTTTACGCAAGC                 61.5      631                   −587/+44
                          SIRT4-P7         *CGGGGTACC*TCGTCATGGCGGGGTATTGG                 62.0      446                   −402/+44
                          SIRT4-P8         *CGGGGTACC*TTGGGCCATCTCTTGTCGAA                 61.0      204                   −160/+44
                          SIRT4-P9         *CGGGGTACC*GAATCGGGTTGACTTG                     63.0      104                   −60/+44
                          SIRT4-R          *CCGCTCGAG*CCCACACTCTCACCTCCAAT                                                 
  **Site-mut and EMSA**   E2F1 forward     TATTTCAAGTCGTCAT*[GGCG]{.ul}*GGGTATTGGGAAAAGT                                   −411/−376
                          E2F1 reverse     ACTTTTCCCAATACCC*[CGCC]{.ul}*ATGACGACTTGAAATA                                   
                          mE2F1 forward    TATTTCAAGTCGTCATGGGTATTGGGAAAAGT                                                
                          mE2F1 reverse    ACTTTTCCCAATACCCATGACGACTTGAAATA                                                
                          CEBPβ forward    CATGGCGGGGTATTGG*[GAAA]{.ul}*AGTTTTCAATTAGCAA                                   −398/−363
                          CEBPβ reverse    TTGCTAATTGAAAACT*[TTTC]{.ul}*CCAATACCCCGCCATG                                   
                          mCEBPβ forward   CATGGCGGGGTATTGGAGTTTTCAATTAGCAA                                                
                          mCEBPβ reverse   TTGCTAATTGAAAACTCCAATACCCCGCCATG                                                
                          HOXA5 forward    ATTGGGAAAAGTTTTC*[AATT]{.ul}*AGCAATAATCGCGCCT                                   −387/−352
                          HOXA5 reverse    AGGCGCGATTATTGCT*[AATT]{.ul}*GAAAACTTTTCCCAAT                                   
                          mHOXA5 forward   ATTGGGAAAAGTTTTCAGCAATAATCGCGCCT                                                
                          mHOXA5 reverse   AGGCGCGATTATTGCTGAAAACTTTTCCCAAT                                                
                          IRF4 forward     TCGTGGATTGAATCTG*[TTTC]{.ul}*CCTGCATACAGTTACA                                   −230/−195
                          IRF4 reverse     TGTAACTGTATGCAGG*[GAAA]{.ul}*CAGATTCAATCCACGA                                   
                          mIRF4 forward    TCGTGGATTGAATCTGCCTGCATACAGTTACA                                                
                          mIRF4 reverse    TGTAACTGTATGCAGGCAGATTCAATCCACGA                                                
                          PAX4 forward     CGGGGAATGTTATGCA*[AATT]{.ul}*AGCATGACGTCACAGA                                   −99/−64
                          PAX4 reverse     TCTGTGACGTCATGCT*[AATT]{.ul}*TGCATAACATTCCCCG                                   
                          mPAX4 forward    CGGGGAATGTTATGCAAGCATGACGTCACAGA                                                
                          mPAX4 reverse    TCTGTGACGTCATGCTTGCATAACATTCCCCG                                                
                          CREB1 forward    GTTATGCAAATTAGCA*[TGAC]{.ul}*GTCACAGAGACGAATC                                   −91/−56
                          CREB1 reverse    GATTCGTCTCTGTGAC*[GTCA]{.ul}*TGCTAATTTGCATAAC                                   
                          mCREB1 forward   GTTATGCAAATTAGCAGTCACAGAGACGAATC                                                
                          mCREB1 reverse   GATTCGTCTCTGTGACTGCTAATTTGCATAAC                                                
  **siRNA**               siSIRT4          F: GGUACUGGGCUAGAAACUUTT                                                        
                                           R: AAGUUUCUAGCCCAGUACCTT                                                        
                          siE2F1           F: CCUCUUCGACUGUGACUUUTT                                                        
                                           R: AAAGUCACAGUCGAAGAGGTT                                                        
                          siCEBPβ          F: CCUCGCAGGUCAAGAGCAATT                                                        
                                           R: UUGCUCUUGACCUGCGAGGTT                                                        
                          siHOXA5          F: GGAGAUCAUAGUUCCGUGATT                                                        
                                           R: UCACGGAACUAUGAUCUCCTT                                                        
                          siIRF4           F: GGGCACUGUUUAAAGGGAATT                                                        
                                           R: UUCCCUUUAAACAGUGCCCTT                                                        
                          siPAX4           F: GGAGCCUGAGACUCCUGAATT                                                        
                                           R: UUCAGGAGUCUCAGGCUCCTT                                                        
                          siCREB1          F: GGUGCCAACUCCGAUUUAUTT                                                        
                                           R: AUAAAUCGGAGUUGGCACCTT                                                        
                          si-NC            F: UUCUCCGAACGUGUCACGUTT                                                        
                                           R: ACGUGACACGUUCGGAGAATT                                                        

The restriction enzyme sites (Kpn I and Xho I) are indicated by the italicized letters in the forward (F) and reverse (R) primers used for promoter cloning and generating overexpression systems. The underlined bases are core putative TF binding sites. Abbreviation: EMSA, electrophoretic mobility shift assay.

Immunofluorescence assays {#sec2-4}
-------------------------

Bovine adipocytes were fixed with 4% paraformaldehyde for 20 min at room temperature and permeabilized with 0.1% Triton X-100 for 10 min. Non-specific binding was blocked by treating permeabilized bovine adipocytes with 5% BSA for 30 min. These cells were then incubated with primary antibody against SIRT4, 2 µg/ml (ab10140; Abcam, U.K.), at 37°C for 2 h, and subsequently incubated with 2% BSA and Cy3-conjugated Donkey Anti-Rabbit IgG (Sangon Biotech, China) at 1:100 dilution for 30 min. All washes were performed using 1× PBS. An anti-fade solution containing 50 ng/ml DAPI (Solarbio, China) was also used to stain the nuclei. Finally, images of the immunofluorescence staining were captured with an Olympus IX71 microscope (Olympus Optical, Tokyo, Japan).

Promoter cloning and generation of luciferase reporter constructs {#sec2-5}
-----------------------------------------------------------------

To clone the bovine *SIRT4* promoter region, gene-specific primers (*SIRT4*-PF/PR, [Table 1](#T1){ref-type="table"}) were designed to amplify a 2-kb promoter region upstream of the TSS. PCR amplifications were performed using genomic DNA, from Qinchuan cattle blood, as a template and KOD DNA Polymerase (Toyobo, Osaka, Japan). After digestion with the restriction enzymes Kpn I and Xho I (TaKaRa, Dalian, China), the 2-kb bovine *SIRT4* promoter fragment, was ligated on to the pGL3-basic vector and named as pGL3-P1. Using pGL3-P1 as a template and with specific primers ([Table 1](#T1){ref-type="table"}) designed to incorporate Kpn I and Xho I, plasmids with unidirectional deletions in the promoter sequence, namely pGL3-P2, P3, P4, P5, P6, P7, P8, and P9, were generated by PCR amplification.

Cell isolation, culture, and transfection {#sec2-6}
-----------------------------------------

Bovine adipocytes were isolated from inguinal adipose tissue collected from 3-day-old post-natal Qinchuan fetal cattle. The inguinal adipose tissue was minced and digested at 37°C for 1.5 h with 1 mg/ml collagenase type I (Invitrogen, U.S.A.), followed by filtration through a nylon mesh (200 μm pore size). The cells were collected by centrifugation at 1500 ***g*** for 10 min and washed thrice with Dulbecco's modified Eagle's medium: Nutrient Mixture F-12 (DMEM/F12; GIBCO, U.S.A.) and suspended in DMEM/F12 medium supplemented with 10% FBS (PAN-Biotech, South America) and antibiotics (100 IU/ml penicillin and 100 µg/ml streptomycin). Subsequently, the cells were seeded on to 100 mm × 20 mm cell culture dishes at a density of 5 × 10^4^ cells/cm^2^ and incubated at 37°C in a humidified atmosphere with 5% CO~2~. After 12 h, fresh DMEM/F12 medium supplemented with 10% FBS and antibiotics (henceforth, this culture medium will be referred to as DMEM/F12 medium and only the other supplementations will be mentioned) was added to the adhered cells. To verify if the isolated bovine cells were actually undifferentiated adipocytes, the medium was replaced with adipogenic differentiation inducing culture medium (DMEM/F12 medium supplemented with 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 1 μM dexamethasone (DEX), and 5 μg/ml insulin) to induce differentiation and incubated for 4 days. We found that with induction both the number and the diameter of the lipid droplets increased, which confirmed that this procedure isolated undifferentiated bovine adipocytes.

Transfections were carried out in 3T3-L1 and bovine adipocytes maintained in DMEM/F-12 medium at 37°C with 100% humidity and 5% CO~2~. Cells were grown overnight in 24-well plates to a confluency of 80%. Each well was treated with the transfection mixture comprising 800 ng of the expression construct (pGL3-P1, P2, P3, P4, P5, P6, P7, P8, and P9), 10 ng of pRL-TK normalizing vector, 2 μl of X-tremeGENE HP DNA transfection reagent (Roche, U.S.A.), and 100 μl of Opti-MEM (GIBCO; Invitrogen) and incubated for 6 h (in triplicate). The pGL3-basic vector served as a negative control. Six hours after transfection, adipogenic differentiation was induced in the 3T3-L1 and bovine adipocytes using the adipogenic differentiation inducing culture medium and incubated for 42 h. Cell lysates were collected 48 h post-transfection and used to measure the relative transcriptional activity of each fragment using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI, U.S.A.) according to the manufacturer's instructions. Relative luciferase activities were determined using a NanoQuant Plate™ (TECAN, infinite M200PRO).

In order to elucidate the regulation of bovine adipocyte differentiation by *SIRT4* and its TFs, differentiation was induced in the undifferentiated bovine adipocytes after transfection with siRNA. To this end, undifferentiated adipocytes were grown in six-well plates until they reached a confluency of 90% (with DMEM/F-12 medium at 37°C with 100% humidity and 5% CO~2~). At this stage, they were transiently transfected with siRNA, 50 nM siRNA was added to each well. Adipogenic differentiation was induced, 6 h after transfection, in culture batches meant to be differentiated by replacing the DMEM/F12 medium with adipogenic differentiation inducing culture medium and incubated for 4 days before the total RNA was harvested. While, the medium of the culture batches meant to be left undifferentiated was replaced with DMEM/F-12 medium only and then incubated for 4 days before harvesting of the total RNA. si-NC served as a control group.

Site-directed mutagenesis {#sec2-7}
-------------------------

To carry out site-directed mutagenesis, putative TF binding sites were first analyzed using the Genomatix suite. The identified putative TF binding sites for E2F1, CEBPβ, HOXA5, IRF4, PAX4, and CREB1 were then mutated using the corresponding primers ([Table 1](#T1){ref-type="table"}) and the QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, U.S.A.). The procedure was carried out in accordance with the manufacturer's instructions. PCR conditions used were also in accordance with the instructions in the kit. The products of the above site-directed mutagenesis procedure were treated with Dpn I, and then amplified using XL10-Gold competent cells (Stratagene); the resulting vectors were sequenced for confirmation.

Knockdown of *SIRT4* and TFs {#sec2-8}
----------------------------

siRNAs targetting *SIRT4, E2F1, CEBPβ, HOXA5, IRF4, PAX4*, and *CREB1* ([Table 1](#T1){ref-type="table"}) were designed and synthesized along with the control siRNA (GenePharma Co., Ltd., Shanghai, China). The si-NC served as a negative control. Bovine adipocytes cultured in six-well plates were transiently co-transfected with 50 nM of each siRNA and the corresponding pGL−402/+44 and pGL−160/+44 vector.

Electrophoretic mobility shift assays {#sec2-9}
-------------------------------------

A LightShift Chemiluminescent EMSA Kit (Thermo Fisher Corp., Waltham, MA, U.S.A.) was used for this assay in accordance with the manufacturer's protocol with some modifications. All DNA probes ([Table 1](#T1){ref-type="table"}) were synthesized (Invitrogen, Carlsbad, CA, U.S.A.) and labeled at the 5′ end with biotin. Nuclear extracts from bovine adipocytes were prepared using the Nuclear Extract Kit (Active Motif Corp., Carlsbad, CA, U.S.A.) according to the manufacturer's protocol. Briefly, 10 μg of nuclear protein extract was incubated with 2 μl of 10× binding buffer and 1 μl of poly (dI-dC) in a 20-μl volume for 15 min on ice. Next, 200 fmol of 5′-biotin labeled probes were added and the reaction mixture was incubated at room temperature (26°C) for 20 min. For the competition assay, unlabeled probes or mutated probes were added to the reaction mixture 15 min before adding the labeled probes. For the super-shift assay, 10 μg of each of the following antibodies were added to the reaction mixture and then incubated on ice for 30 min before adding the labeled probes: anti-E2F1 (ab179445; Abcam, U.K.), anti-CEBPβ (sc-746; Santa Cruz, U.S.A.), anti-HOXA5 (sc-13199; Santa Cruz, U.S.A.), anti-IRF4 (sc-28696; Santa Cruz, U.S.A.), anti-PAX4 (ab42450; Abcam, U.K.), and anti-CREB1 (ab32515; Abcam, U.K.). Finally, the DNA--protein complexes were separated on a 6% non-denaturing polyacrylamide gel by electrophoresis, using 0.5× Tris-borate-EDTA buffer, for 1 h. Images were captured using the molecular imager ChemiDoc™ XRS+ system (Bio-Rad, Hercules, California, U.S.A.).

Statistical analysis {#sec2-10}
--------------------

Statistical calculations were performed using the Statistical Analysis System (SAS) v8.0 (SAS Institute, Cary, NC). Statistical significance was determined using one-way ANOVA test. Results for gene expression and luciferase assay were based on three independent experiments. Data are expressed as mean ± S.D.; *P*\<0.05 was considered significant (\* denotes significance at *P*\<0.05 and \*\* denotes significance at *P*\<0.01).

Results {#sec3}
=======

Gene expression pattern and subcellular localization of *SIRT4* in bovine adipocytes {#sec3-1}
------------------------------------------------------------------------------------

The spatial expression pattern of bovine *SIRT4* was studied, and the results showed highest expression in the testis followed by subcutaneous fat ([Figure 1](#F1){ref-type="fig"}A; *P*\<0.05). We then measured mRNA levels of *SIRT4* during bovine adipocyte differentiation. We found that *SIRT4* expression increased before the seventh day of differentiation, which was followed by a decline over the remainder of differentiation ([Figure 1](#F1){ref-type="fig"}B; *P*\<0.05). To further explore the effect of *SIRT4* on the differentiation of bovine adipocytes, the expression levels of *SIRT4* were effectively reduced by siRNA during differentiation. Results showed that the expression of marker genes that promote bovine adipocyte differentiation was significantly inhibited after *SIRT4* knockdown ([Figure 1](#F1){ref-type="fig"}C; *P*\<0.05). The cytoplasmic subcellular localization of bovine SIRT4 was confirmed by immunofluorescence experiments; SIRT4 was found to localize in adipocyte mitochondria ([Figure 1](#F1){ref-type="fig"}D). These results suggested that *SIRT4* might be tightly associated with adipose development.

![Gene expression pattern and subcellular localization of *SIRT4*\
(**A**) Analysis of the bovine *SIRT4* spatial expression pattern in tissues and organs. (**B**) Relative mRNA expression levels of *SIRT4* during different stages of bovine adipocyte differentiation. (**C**) During adipocyte differentiation, the expression of marker genes that promote bovine adipocyte differentiation was significantly inhibited after *SIRT4* knockdown. (**D**) SIRT4 immunofluorescence (red) in bovine adipocytes; nuclei were visualized by DAPI staining (blue). A merged figure is shown in the right panel. The top left photograph provides magnified images as indicated by the arrows. Values are represented as mean ± S.D. \* indicates significance at *P*\<0.05 and \*\* indicates significance at *P*\<0.01 compared with the control group. Error bars represent the S.D.](bsr-38-bsr20181705-g1){#F1}

Isolation and sequence analysis of the core promoter of bovine *SIRT4* {#sec3-2}
----------------------------------------------------------------------

We further explored the activity of potential *cis*-acting elements and identified the key sequence required for their activity. We constructed a series of reporter vectors with progressively larger deletions, from the 5′ end of the promoter. Results of luciferase reporter assays using 3T3-L1 and bovine adipocytes identified a core promoter in the −402 bp/−60 bp region of *SIRT4* ([Figure 2](#F2){ref-type="fig"}A,B; *P*\<0.05). In addition, the analysis using the MethPrimer program discovered a CpG island located in the −378 bp/+18 bp region, which was found to be highly similar to the core promoter in the −402 bp/−60 bp region ([Figure 2](#F2){ref-type="fig"}C). We further analyzed regulatory elements in the *SIRT4* −2077 bp/+44 bp promoter region using the Genomatix suite. Six motifs including TF binding sites for E2F1, CEBPβ, HOXA5, IRF4, PAX4, and CREB1 were identified in the core promoter region ([Figure 2](#F2){ref-type="fig"}D).

![Isolation and sequence analysis of the core promoter of *SIRT4*\
(**A**,**B**) Depiction and reporter assay results for the series of plasmids containing 5′ unidirectional deletions in the promoter region of *SIRT4* fused in-frame to the luciferase gene. These plasmids were transfected into 3T3-L1 or bovine adipocytes. (**C**) Schematic representation of the relative loci of the potential motif binding sites in the *SIRT4* promoter. Dashed lines indicate the GC percentage as represented by the y-axis; the x-axis denotes the bp position in the 5′ UTR. (**D**) Sequence of the 5′ regulatory region of bovine *SIRT4*. Arrows mark the transcription initiation sites. The translational start site is shown in red letters. The TF binding sites are boxed and primer sequences are underlined with respective names shown below the line. \* indicates significance at *P*\<0.05 and \*\* indicates significance at *P*\<0.01 compared with the control group. Error bars represent the S.D.](bsr-38-bsr20181705-g2){#F2}

Identification of TFs that function as transcriptional activators or repressors in the *SIRT4* core promoter region {#sec3-3}
-------------------------------------------------------------------------------------------------------------------

To identify the functions of TFs in the regulation of bovine *SIRT4*, we constructed a series of DNA plasmids with 4-bp point mutations in the TF binding motifs, and transfected these into 3T3-L1 and bovine adipocytes. As shown, mutating IRF4 site in the pGL−402/+44 construct and the PAX4 and CREB1 sites in the pGL−160/+44 construct resulted in a significant increase in *SIRT4* promoter activity; in contrast, mutating the E2F1, CEBPβ, and HOXA5 sites in the pGL−402/+44 construct resulted in a significant decrease in *SIRT4* promoter activity ([Figure 3](#F3){ref-type="fig"}A; *P*\<0.05). Next, siRNAs targetting *E2F1, CEBPβ, HOXA5, IRF4, PAX4*, and *CREB1* were designed, synthesized, and transfected into bovine adipocytes to detect the knockdown efficiency of respective genes. Results indicated that the expression levels of these TFs were effectively reduced ([Figure 3](#F3){ref-type="fig"}B; *P*\<0.05). We then utilized these siRNAs to determine the effect of knocking down the TFs involved in *SIRT4* expression. *E2F1, CEBPβ*, and *HOXA5* knockdown down-regulated *SIRT4* mRNA expression, whereas ablation of *IRF4, PAX4*, and *CREB1* up-regulated *SIRT4* mRNA levels ([Figure 3](#F3){ref-type="fig"}C; *P*\<0.05). To further validate the results, siRNAs targetting the TFs and pGL−402/+44 or pGL−160/+44 were co-transfected, which obviously altered activity of the *SIRT4* promoter. The transcriptional activity was significantly decreased when *E2F1, CEBPβ*, or *HOXA5* were knocked down, whereas it was increased when *IRF4, PAX4*, or *CREB1* were suppressed ([Figure 3](#F3){ref-type="fig"}D; *P*\<20.05).

![Identification of the E2F1, CEBPβ, HOXA5, IRF4, PAX4, and CREB1 as transcriptional activators or repressors in the core promoter region of *SIRT4*\
(**A**) Luciferase assays after transfection of constructs generated by site-directed mutagenesis of TF binding sites. White and black fill in sequence depictions represent wild and mutant types, respectively. (**B**) Knockdown efficiency of si*E2F1*, si*CEBPβ*, si*HOXA5*, si*IRF4*, si*PAX4*, and si*CREB1*. (**C**) Relative *SIRT4* mRNA expression in cells transfected with siRNAs targetting TFs. (**D**) Luciferase reporter assays after *E2F1, CEBPβ, HOXA5, IRF4, PAX4*, and *CREB1* knockdown by siRNA and co-transfection with pGL−402/+44 and pGL−160/+44 in bovine adipocytes. si-NC was used as a negative control. \* indicates significance at *P*\<0.05 compared with the control group. Error bars represent the S.D.](bsr-38-bsr20181705-g3){#F3}

TFs bind to the core promoter region of *SIRT4* {#sec3-4}
-----------------------------------------------

Electrophoretic mobility shift assays (EMSAs) were then performed to assess binding of E2F1, CEBPβ, HOXA5, IRF4, PAX4, and CREB1 to the *SIRT4* core promoter. As shown (lane 2, [Figure 4](#F4){ref-type="fig"}A), bovine adipocyte nuclear protein binds the 5′-biotin labeled E2F1 probes and forms one predominant complex. Competition assays determined that the mutant probe had a negligible effect on this complex (lane 3, [Figure 4](#F4){ref-type="fig"}A). At the same time, the specific E2F1/DNA interaction was prevented by competition from excess unlabeled DNA (lane 4, [Figure 4](#F4){ref-type="fig"}A). The last lane indicates that the complex was super-shifted upon incubation with an anti-E2F1 antibody (lane 5, [Figure 4](#F4){ref-type="fig"}A). CEBPβ, HOXA5, IRF4, PAX4, and CREB1 probes yielded similar results ([Figure 4](#F4){ref-type="fig"}B,C,D,E, and F). In the all EMSAs, we found that the upshifted bands were diminished with antibody addition. These results indicated that the TFs bind to the core promoter region of the *SIRT4 in vitro*.

![Identification of TFs binding to the core promoter of *SIRT4* using EMSAs\
EMSAs showing direct binding of E2F1, CEBPβ, HOXA5, IRF4, PAX4, and CREB1 to the *SIRT4* promoter *in vitro*; nuclear protein extracts were incubated with 5′-biotin labeled probes for (**A**) E2F1, (**B**) CEBPβ, (**C**) HOXA5, (**D**) IRF4, (**E**) PAX4, or (**F**) CREB1 binding sites in the presence or absence of competitor (lane 2), a 50× concentration of mutated probe (lane 3), and a 50× concentration of unlabeled probes (lane 4). The super-shift assay was conducted using 10 μg of anti-E2F1, anti-CEBPβ, anti-HOXA5, anti-IRF4, anti-PAX4, or anti-CREB1 antibodies (lane 5). The arrows indicate the main complexes. Abbreviation: adipocyte NE, adipocyte nuclear protein extract.](bsr-38-bsr20181705-g4){#F4}

TFs and *SIRT4* gene cooperatively regulated the relative expression of adipocyte differentiation marker genes {#sec3-5}
--------------------------------------------------------------------------------------------------------------

To confirm whether the degree to which the bovine adipocytes had differentiated was appropriate for the study, we first ascertained the relative expression levels of marker genes in undifferentiated and differentiated cultures of adipocytes; results revealed that the expression of the marker genes changed significantly in the cultures induced to differentiate ([Figure 5](#F5){ref-type="fig"}A; *P*\<0.05). The differences in expression of the six TFs were also ascertained in undifferentiated and differentiated bovine adipocytes ([Figure 5](#F5){ref-type="fig"}B; *P*\<0.05).

![TFs and *SIRT4* cooperatively regulated the relative expression of adipocyte differentiation marker genes\
(**A**) The relative expression levels of marker genes in undifferentiated and differentiated stages of bovine adipocytes. (**B**) The differences in expression of TFs in undifferentiated and differentiated bovine adipocytes. (**C**--**H**) *E2F1, CEBPβ*, and *HOXA5* knockdown significantly down-regulated the expressions of marker genes that promote adipocyte differentiation; while the ablation of *IRF4, PAX4*, and *CREB1* significantly up-regulated the expressions of marker genes. *E2F1, CEBPβ, HOXA5*, and *SIRT4* had the same regulatory effect on the expression of adipogenic marker genes, and *SIRT4* coordinated with *E2F1, CEBPβ*, and *HOXA5* in promoting adipocyte differentiation. On the contrary, the regulation of *IRF4, PAX4*, and *CREB1* on the expression of adipogenic marker genes was opposite to the effect of *SIRT4*, and *SIRT4* was able to counteract the negative regulation of *IRF4, PAX4*, and *CREB1* on the adipocyte differentiation.](bsr-38-bsr20181705-g5){#F5}

In order to detect the regulation of differentiation in bovine adipocytes by *SIRT4* and TFs, we knocked down the *SIRT4* and TFs using siRNAs. The results showed that these TFs have a significant regulatory effect on the expression of marker genes during adipocyte differentiation. In particular, interference of *E2F1, CEBPβ*, and *HOXA5* significantly down-regulated the expression of adipogenesis marker genes, which promote adipocyte differentiation ([Figure 5](#F5){ref-type="fig"}C--E; *P*\<0.05). However, the expression of adipogenic differentiation marker genes was significantly up-regulated with the interference of *IRF4, PAX4*, and *CREB1* ([Figure 5](#F5){ref-type="fig"}F--H; *P*\<0.05). Since these TFs bind to the core promoter region of *SIRT4*, and *SIRT4* also has a significant regulatory effect on adipocyte differentiation, we assumed that TFs coordinate with *SIRT4* to regulate adipocyte differentiation. In order to verify this hypothesis, we knocked down *SIRT4* with interference of each TF separately by siRNAs during adipocyte differentiation, and then detected the expression level of the differentiation marker genes. The results showed that TFs and *SIRT4* interact coordinately in promoting adipocyte differentiation. *E2F1, CEBPβ, HOXA5*, and *SIRT4* all increase the expression of adipogenic marker genes. Moreover, *SIRT4* synergized the effects of *E2F1, CEBPβ*, and *HOXA5* on adipocyte differentiation ([Figure 5](#F5){ref-type="fig"}C--E; *P*\<0.05). However, *IRF4, PAX4, CREB1* significantly down-regulated the mRNA expression of adipogenic marker genes, in addition, *SIRT4* antagonized the inhibitory effects of *IRF4, PAX4*, and *CREB1* on adipocyte differentiation ([Figure 5](#F5){ref-type="fig"}F--H; *P*\<0.05). Based on above results, we concluded that *SIRT4* is a vital downstream effector of these TFs in not only the pathways regulating adipocyte differentiation, but also in pathways regulating fatty acid oxidation, lipid deposition, and adipocyte growth.

Discussion {#sec4}
==========

Energy metabolism is an important aspect of metabolism; metabolism of glucose and lipid is critical to maintain cell energy homeostasis. In the physiological and biochemical processes of cells, glucose and lipid metabolism is primarily regulated by caloric restriction, oxidative stress, or other changes in energy \[[@B12]\]. Therefore, the focus of biological research has been on the main molecules that regulate metabolism in cell survival and homeostasis. Amongst these regulators, sirtuins have been the new research hotspots because of their important roles in regulating and maintaining glucose and lipid homeostases. Moreover, the biological functions of sirtuins have been confirmed to vary vastly from being involved in metabolism to being core regulators of cell survival \[[@B12],[@B37]\].

Mammalian SIRT4 is localized to the mitochondria and plays an important role in regulating mitochondrial gene expression and fatty acid oxidation in liver and adipocytes \[[@B25],[@B38],[@B39]\]. The decreased expression level of *SIRT4* usually leads to a significant increase in the expression of enzymes involved in fatty acid oxidation metabolism \[[@B40]\]. *SIRT4* liver-specific KO mice display an increased expression of PPARα target genes associated with fatty acid catabolism \[[@B22]\]. *SIRT4* tissue-specific KO mouse models could also be critical providing a comprehensive view of SIRT4 functions in fatty acid metabolism. In the present study, we found high mRNA expression of *SIRT4* in bovine subcutaneous fat; *SIRT4* expression increased before the seventh day of differentiation and then decreased with the differentiation of bovine adipocytes; further, the expression of marker genes that promote bovine adipocyte differentiation were significantly inhibited by *SIRT4* knockdown. These results suggested that *SIRT4* might have an important role in regulating the development of bovine adipose tissue \[[@B17],[@B18]\].

The E2F TF family plays a crucial role in modulation of tumor suppressor proteins and in the control of cell cycle; it has also been identified as a target of the transforming proteins of small DNA tumor viruses \[[@B41],[@B42]\]. E2F1 has an additional cyclin-binding domain, and plays a key role in metabolism beyond the control of the cell cycle in non-proliferating cells \[[@B43],[@B44]\]. CCAAT-enhancer binding proteins (C/EBPs) are key TFs that control cellular proliferation, differentiation, metabolism, inflammation, and numerous other responses, particularly in adipocytes \[[@B30],[@B45]\]. CEBPβ are transiently induced during the early stages of adipocyte differentiation \[[@B30]\], and the ectopic expression of CEBPβ in 3T3-L1 promotes adipogenesis, even in the absence of adipogenic stimuli \[[@B46],[@B47]\]. Expression of *Homeobox* genes is spatially and temporally regulated during embryonic development. *HOXA5* encodes a DNA-binding TF, which may regulate gene expression, morphogenesis, and differentiation \[[@B31]\]. *HOXA5* is controlled by DNA methylation \[[@B48]\], and has been shown to up-regulate the tumor suppressor p53 and AKT1 by down-regulation of PTEN \[[@B49]\]. *Homeobox* genes also have a functional role in determining adipose tissue expansion and body fat distribution, and it has been reported that HOXA5 promotes adipose differentiation in mice \[[@B31],[@B50]\]. Interferon regulatory factors are proteins, which regulate transcription of interferons and play key roles in the JAK-STAT signaling pathway \[[@B51]\]. IRF4 has been implicated in acute leukemia \[[@B52]\], and strongly associated with pigmentation traits such as sensitivity of skin to sun exposure, freckles, blue eyes, and brown hair color \[[@B53]\]. IRF4 was also identified as an important regulator of adipogenesis and adipose lipid handling; it also regulates isoproterenol-stimulated glycerol release in adipose tissue both *ex vivo* and *in vivo* \[[@B54],[@B55]\]. PAX family plays critical roles during fetal development and cancer growth. PAX4 is involved in pancreatic islet development, mouse studies have demonstrated PAX4 is a key mediator of the generation of insulin-producing β-cells during embryonic development \[[@B56],[@B57]\]. CREB1 is a member of the leucine zipper family of DNA-binding proteins, it stimulates transcription by binding the cAMP response element, a DNA sequence present in many gene promoters \[[@B58]\]. CREB1 is phosphorylated by several protein kinases, and induces transcription of genes in response to hormonal stimulation of the cAMP pathway \[[@B59]\]. CREB1 has already been confirmed to be a well-documented TF, which is involved in adipocyte differentiation and lipid metabolism \[[@B60],[@B61]\].

To elucidate the regulatory mechanism of bovine *SIRT4* expression, we analyzed the 5′ regulatory region of this gene using online prediction software, and found putative binding sites for the following TFs, namely E2F1, CEBPβ, HOXA5, IRF4, PAX4, and CREB1 at the −402/−60 bp core promoter region of the *SIRT4*. We hypothesized that these TFs might play major roles in regulating the transcriptional activity of *SIRT4*, and TFs can coordinate with *SIRT4* to regulate adipocyte differentiation. We found that E2F1, CEBPβ, and HOXA5 are transcriptional activators of *SIRT4* and IRF4, PAX4, and CREB1 transcriptional repressors of *SIRT4*. We also showed that *SIRT4* could affect the ability of these TFs in regulating the adipocyte differentiation. These results confirm the coordinate regulation by *SIRT4* and TFs on adipose differentiation.

Conclusion {#sec5}
==========

In summary, we revealed high *SIRT4* expression in bovine adipose tissue, which increased before the seventh day of adipocyte differentiation. During adipocyte differentiation, the expression of marker genes that promote adipocyte differentiation was significantly inhibited after *SIRT4* knockdown. We identified the core promoter of the bovine *SIRT4* gene and determined that *SIRT4* is regulated by various TFs: E2F1, CEBPβ, and HOXA5 as transcriptional activators, whereas IRF4, PAX4, and CREB1 as transcriptional repressors. Moreover, we elucidated the regulatory mechanisms of TFs in adipocyte differentiation. Further, we verified that *SIRT4* knockdown could affect the ability of TFs in regulating the differentiation of bovine adipocytes. These data provide a foundation to better understand the transcriptional regulation and biological function of bovine *SIRT4* in adipocyte differentiation ([Figure 6](#F6){ref-type="fig"}).

![Proposed schematic summary of the regulation of differentiation of bovine adipocytes by *SIRT4* and its TFs\
In short, *SIRT4* promotes the differentiation of bovine adipocytes, E2F1, CEBPβ, and HOXA5 increase the *SIRT4* promoter activity, while IRF4, PAX4, and CREB1 decrease the *SIRT4* promoter activity.](bsr-38-bsr20181705-g6){#F6}
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3T3-L1

:   mouse pre-adipose embryo fibroblast

C/EBP

:   CCAAT enhancer binding protein

CEBPβ

:   CCAAT enhancer binding protein β

CpG

:   5′---C---phosphate---G---3′

CREB1

:   cAMP responsive element-binding protein 1

DMEM/F12

:   Dulbecco's modified Eagle's medium: nutrient mixture F-12

E2F1

:   E2F transcription factor 1

EMSA

:   electrophoretic mobility shift assay

HOXA5

:   homeobox A5

IDE

:   insulin degrading enzyme

IRF4

:   interferon regulatory factor 4

JAK-STAT

:   janus kinase-signal transducers and activators of transcription

KO

:   knockout

KOD

:   thermococcus kodakarensis

MCD

:   malonyl-CoA decarboxylase

PAX4

:   paired box 4

PPARα

:   peroxisome proliferator-activated receptor alpha

qPCR

:   real-time quantitative PCR

si-NC

:   negative control siRNA

SIRT4

:   sirtuin 4

TF

:   transcription factor

TSS

:   transcription start site
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